相关实验视频

Updated: Jun 21, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

临床性氨基菌性皮肤炎:临床,实验室和组织病理学特征

Xintong Wang¹, Ellen De Moll², Merav Koschitzky³

¹Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Journal of cutaneous pathology

|July 15, 2024

概括

临床上氨基性皮肤肌炎 (CADM) 亚型,氨基性皮肤肌炎 (ADM) 和低氨基性皮肤肌炎 (HDM),表现出明显的临床病理特征. 了解这些差异有助于诊断具有挑战性的皮肤病变.

科学领域:

皮肤病学皮肤病学
类风湿病学类风湿病学
病理学病理学病理学

背景情况:

尽管取得了进展,临床上 Amyopathic Dermatomyositis (CADM) 的分类和诊断仍然具有挑战性.
将CADM分类为白血病性皮肤肌炎 (ADM) 和低血病性皮肤肌炎 (HDM) 需要进一步的临床病理学定义.

研究的目的:

描述CADM的临床病理特征.
评估和突出ADM和HDM皮肤病理学发现之间的差异.

主要方法:

在2016-2020年间诊断的43名CADM患者的回顾性研究.
患者被分为ADM (n=30) 和HDM (n=13) 组.
分析了临床病理特征和自身抗体概况.

主要成果:

在所有患者中都观察到特征性的皮肤表现.
常见的自身抗体包括ANA,RNP和抗Ro52.
组织病理学发现显示了粘素沉积,telangiectasia和淋巴细胞透.
与HDM患者相比,ADM患者的表皮缩显著减少 (3.3%与38.5%相比),粘素沉积更多 (80.0%与46.2%相比).

结论:

该研究描述了ADM和HDM之间的关键临床病理学区别.
这些发现可以帮助诊断CADM患者的模两可的皮肤病变.

关键词:

氨基病性皮肤肌肉学炎临床上是氨基变异性皮肤肌肉炎.低肌病性皮肤肌肉性炎症

更多相关视频

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...